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Background: Optical coherence tomography (OCT) has become a promising diagnostic tool in many medical
fields. In particular, noninvasive real-time optical biopsy of internal organs is one of the most attractive applications
of OCT, enabling in situ diagnosis of carcinoma at an early stage. We used an ultra-high speed OCT system for
real-time three-dimensional (3D) imaging of three excised specimens of advanced urothelial carcinoma (UC) and
investigated the association of the images with results from histopathological examination.
Case presentations: Case 1 was a 69-year-old man underwent radical cystectomy for muscle-invasive UC (pT2).
Case 2 was a 53-year-old man underwent laparoscopic nephroureterectomy and partial cystectomy for left ureter
carcinoma (pT2) and case 3 was a 77-year-old woman underwent radical cystectomy for advanced bladder
carcinoma (pT3b). Real-time 3D OCT images of normal bladder wall and ureter showed three layers, including the
urothelium, lamina propria, and muscularis layer. In contrast, normal structure was not seen in the muscle-invasive
UC area or the scar tissue area.
Conclusions: This study highlighted a new diagnostic method with potential application for UC diagnosis. We will
investigate more cases in the future and expect improvement in the diagnosing efficiency of carcinoma in situ or
organ-confined muscle-invasive cancer by cystoscopy or ureteroscopy with ultra-high speed OCT.
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Real-time optical biopsyBackground
An estimated 386,300 new cases of urothelial carcinoma
(UC) of the bladder occurred in 2008, during which the
disease accounted for 150,200 deaths worldwide [1].
Nonmuscle-invasive UC accounts for more than 70% of
newly diagnosed cases [2] and includes carcinoma in situ
(CIS), a flat, high-grade, noninvasive intraurothelial
carcinoma with a high risk of aggressive progression.
Early detection and treatment of recurrent disease are
required to maximize bladder preservation and patient
survival [3]. However, early diagnosis of CIS, which is
crucial for appropriate treatment, remains a clinical* Correspondence: ikeda.masaomi@grape.plala.or.jp
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reproduction in any medium, provided the orchallenge. Conventional imaging methods, such as x-ray,
computerized tomography (CT) and magnetic resonance
imaging (MRI), fail to detect early UC due to their lim-
ited resolution. Although urinary cytology, fluorescence
in situ hybridization and bladder tumor antigen test are
highly sensitive screening techniques for the clinical de-
tection of CIS and high grade UC, they cannot identify
carcinoma locations to effectively guide transurethral re-
section (TUR) and treatment [4]. Cystoscopy, the direct
visualization of the bladder surface via optical fibre bun-
dles, is the current gold standard for the diagnosis of
UC. In addition, narrow band imaging (NBI) cystoscopy
can increase bladder cancer visualization and detection
at the time of TUR [5-8]. However, cystoscopy some-
times misses flat lesions such as CIS, which may be visu-
ally normal. Therefore, conclusive diagnosis and stagingtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Excised specimen of left ureter carcinoma (pT2a).
(A) Normal ureter wall. (B) Left ureter carcinoma.
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random biopsy, which may miss almost 50% of early flat
UC [9].
Optical coherence tomography (OCT) is an emerging
technology that provides noninvasive, real-time high-
resolution (10 to 20 μm) imaging of the bladder wall in
cross-section, showing the urothelium, lamina propria,
and muscularis layer to a depth of about 2 mm. OCT for
medical diagnostics was first reported by Huang et al.
[10], and it has become a promising diagnostic tool for,
among others, retinal diseases in ophthalmology, esopha-
geal and pancreatico-biliary diseases in gastroenterology,
and cutaneous diseases in dermatology. Noninvasive real-
time optical biopsy of internal organs is one of the most
attractive applications of OCT enabling in situ diagnosis
of carcinoma at an early stage.
Recently, Ohbayashi et al. [11] and Choi et al. [12]
reported an ultra-fast data processing system installed
in an ultra-high speed OCT system that enables real-
time display of various three-dimensional (3D) images
without the limitation of diagnostic time. We used
this new system to investigate real-time 3D imaging
of excised tissue from three patients with advanced




We reported OCT measurement previously [11,12].
Briefly, all the cases were measured by ultra-high speed
OCT system immediately after radical cystectomy or
nephroureterectomy. The OCT imaging area was dem-
onstrated around 12 mm from the probe, and the depth
is approximately 4 mm. We investigated images consist-
ing mainly of the three areas such as cancerous, normal
and boundary areas, and compared the histopathological
examination of the same area.
Case 1
A 69-year-old man underwent radical cystectomy for
muscle-invasive UC (pT2). Histopathological examin-
ation revealed no evidence of malignancy (pT0) or scar
tissue after TUR of the bladder. OCT images of normal
bladder wall were characterized by three layers: a thin,
dark upper layer representing the urothelium and a sec-
ond bright layer corresponding to the lamina propria,
followed by the thick, dark muscularis layer. In contrast,
the three characteristic layers were not found in the scar
tissue area. There was no thin, dark upper layer like the
urothelium. The two layers that were observed, a bright
thick layer and a dark thick layer, were revealed using
OCT. OCT showed no residual tumorous lesion in the
bladder wall.Case 2
A 53-year-old man underwent laparoscopic nephroure-
terectomy and partial cystectomy for left ureter carcin-
oma (Figure 1). Histopathological examination revealed
UC, pT2, grade 2 > 3. OCT images from a normal part of
the ureter confirmed three layers, including the urothe-
lium, lamina propria, and muscularis layer (Figure 2A, C).
A single layer was seen in the advanced ureter carcinoma
area (Figure 2B, D), and there were no normal structures.
Case 3
A 77-year-old woman underwent radical cystectomy for
advanced bladder carcinoma. Histopathological examin-
ation revealed small cell carcinoma, pT3b. Similar to the
other cases, there were no distinguishable structural
layers in OCT images of the muscle-invasive bladder
cancer. Muscle-invasive lesions showed complete oblit-
eration of any defined layers of the bladder wall.
Discussion
TUR followed by histopathological examination is cur-
rently the standard for assessing depth of tumor penetra-
tion, which is a key determinant in treatment of bladder
cancer. Pathologic stage is one of the strongest prognostic
Figure 2 Real-time 3D imaging by ultra-high speed OCT and histopathological examination of normal ureter wall and muscle-invasive
urothelial carcinoma. (A) A representative real-time 3D OCT image of normal ureter wall was characterized by three layers: a thin, dark upper
layer for the urothelium (U) and a second bright layer corresponding to the lamina propria (LP), followed by the thick, dark muscularis layer (MP).
(B) There were no layer structures in muscle-invasive ureter carcinoma area. (C, D) Histopathological images corresponding to (A) and
(B), respectively.
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sampling is often limited for tissue analyses using TUR
because of insufficient tissue collection, degeneration
from coagulation and heterogeneous distribution of
CIS in the bladder wall. In addition, conventional
cystoscopy provides limited information regarding
changes in the bladder wall, particularly below the
surface. Therefore, when performing biopsy or resec-
tion, an urologist is guided only by the visual appear-
ance of the tumor. Experienced urologists are able to
differentiate benign or malignant lesions visually, but
their ability to estimate grade and stage with cystos-
copy alone is less accurate [14]. Overcoming these
clinical limitations, NBI has been shown to increase
the detection rate. NBI is an optical enhancement
technology that consists of two bandwidths of illu-
mination centred on 415 nm (blue) and 540 nm
(green) that can increase the contrast between vascu-
lature and superficial tissue structures of the mucosa
[15]. Randomized prospective studies [5,6] and retro-
spective studies [7,8] have shown that NBI-assisted
TUR could significantly reduce the residual tumor
and recurrence risk. However, the NBI system is not
suited to assessing the depth of tumor penetration.
While conventional methods of imaging, including CT
and MRI, have been useful for detecting advanced disease,
they have done poorly in identifying nonmuscle-invasive
cancer, particularly for CIS, or muscle-invasive cancer like
T2a. This ultra-high speed OCT system may detect CIS
that is not observed structural changes of submucosa incystoscopy. In addition, it may diagnose the depth of the
tumor penetration which cannot be seen in NBI. We be-
lieve that both detection of tumor and assessing the depth
of tumor penetration by real-time 3D OCT can aid
current modalities and lead to performing a precious diag-
nosis before the surgery in the future.
OCT provides unique information about underlying
tissue microstructure that can augment diagnosis and
improve staging of bladder cancer. The feasibility of
OCT to delineate normal and abnormal bladder tissue
has been shown in previous studies [16,17], and OCT
has demonstrated excellent high sensitivity and specifi-
city. Manyak et al. [16] evaluated 87 areas of interest; 16
were diverse papillary lesions, 36 areas were termed
“visually suspicious for malignancy”, and 35 areas were
relatively normal in appearance. OCT had an overall
sensitivity of 100%, overall specificity of 89%, positive
predictive value of 75%, and negative predictive value of
100%. Goh et al. [18] reported the results of 94 OCT
images in 32 patients. Muscle-invasive bladder cancers
were detected with 100% sensitivity and 90% specificity.
The sensitivity and specificity for Ta lesions were 90%
and 89%, respectively. However, the conventional
OCT system is only two-dimensional imaging, and modi-
fication of image capture in 3D is much more time-
consuming with current modalities.
Recently, our institution developed the ultra-high
speed OCT system that enables real-time display of vari-
ous 3D images without the limitation of diagnostic time.
We had performed pre-clinical experiments of real-time
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porcine model. Real-time OCT was shown precious
layers like histologic finding on the images. According to
these results, we firstly reported biological images of
real-time OCT in human bladder and ureter. These 3
cases were examined from the lumen side of bladder or
ureter. In addition, we can take images whole bladder and
ureter area, including cancerous, normal and boundary
areas. However, the imaging area by this new OCT system
was demonstrated around 12 mm from the probe, and
the depth is approximately 2 mm from the urothelium.
In our experience, the perivesical fat layer was deeply
located from the probe and cannot be observed using
current system.
In this study we examined real-time 3D imaging by
ultra-high speed OCT of exenterated advanced UC and
compared the images with results from histopathological
examination. First, the real-time 3D OCT images of
normal bladder wall and ureter were confirmed three
tissue layers, specifically the urothelium, lamina pro-
pria, and muscularis layer. Second, there were no struc-
tural layers in the muscle-invasive UC area. Third, the
three characteristic layers were not found in the scar
tissue area.
A limitation of this study was that real-time 3D im-
aging was done on an excised specimen and not a
preoperative sample. We diagnosed these 3 cases as
advanced UC preoperatively by the existing diagnostic
modalities of CT or MRI. Therefore, simple compari-
sons of CT with OCT images were relatively difficult. In
addition, all three patients were advanced UC cases, and
there was neither a nonmuscle-invasive UC nor a CIS
case. However, in real-time 3D OCT, it may be possible to
immediately identify nonmuscle-invasive UC range, par-
ticularly for CIS. In a lesion suspicious for muscle-invasive
UC, real-time 3D OCT may show precious diagnosis with
no three-layer structures and may avoid the need for a
second TUR.
Conclusions
This study highlighted a new diagnostic method with
potential application for UC diagnosis. We conducted
real-time 3D imaging of advanced UC by ultra-high
speed OCT. We will investigate additional cases and ex-
pect that cystoscopy or ureteroscopy with ultra-high
speed OCT will be developed in the future.
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